Mei-Chiung Shih

Publications

• Adaptive trial designs. Lai TL, Lavori PW, Shih MC. Annu Rev Pharmacol Toxicol. 2012: 52 101-10
• Clinical trial designs for testing biomarker-based personalized therapies. Lai TL, Lavori PW, Shih MC, Sikic BI. Clin Trials. 2012; 9 (2): 141-54
• Sequential design of phase II-III cancer trials. Lai TL, Lavori PW, Shih MC. Stat Med. 2012; 31 (18): 1944-60
• A biosensor platform for rapid antimicrobial susceptibility testing directly from clinical samples. Mach KE, Mohan R, Baron EJ, Shih MC, Gau V, Wong PK, Liao JC. J Urol. 2011; 185 (1): 148-53
• An evaluation of patient self-testing competency of prothrombin time for managing anticoagulation: pre-randomization results of VA Cooperative Study #481--The Home INR Study (THINRS). Dolor RJ, Ruybalid RL, Uyeda L, Edson RG, Phibbs C, Vertrees JE, Shih MC, Jacobson AK, Matchar DB. J Thromb Thrombolysis. 2010; 30 (3): 263-75
• Defining acute lung disease in children with the oxygenation saturation index. Thomas NJ, Shaffer ML, Willson DF, Shih MC, Curley MA. Pediatr Crit Care Med. 2010; 11 (1): 12-7